期刊
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
卷 22, 期 16, 页码 -出版社
MDPI
DOI: 10.3390/ijms22169044
关键词
natural killer cells; innate lymphoid cells; ILC1; liver; hepatocellular carcinoma; cancer; immunotherapies
资金
- CIHR
- CCS
- National Health and Medical Research Council (NHMRC) of Australia [GNT1098832, GNT1165443, GNT1135898, GNT2002265]
- Australian Research Career development Fellowship [GNT1123000]
- Cancer Council NSW [RG 21-05]
- Priority-driven Collaborative Cancer Research Scheme
- Cure Cancer [1158085]
- US Department of Defense-Breast Cancer Research Program-Breakthrough Award Level 1 [BC200025]
- UQ Diamantina Institute Laboratory Start-Up Package
- Cancer Australia
NK cells and ILC1 are specific innate lymphoid cell subsets crucial for detecting and eliminating pathogens and cancer cells. In the liver, they contribute to organ homeostasis through cytokine production and elimination of harmful microbes, with potential for targeted immunotherapies in hepatocellular carcinoma. Understanding the distinct roles and functions of these innate immune cells in liver cancer could lead to new treatment strategies.
Natural killer (NK) cells and type 1 innate lymphoid cells (ILC1) are specific innate lymphoid cell subsets that are key for the detection and elimination of pathogens and cancer cells. In liver, while they share a number of characteristics, they differ in many features. These include their developmental pathways, tissue distribution, phenotype and functions. NK cells and ILC1 contribute to organ homeostasis through the production of key cytokines and chemokines and the elimination of potential harmful bacteria and viruses. In addition, they are equipped with a wide range of receptors, allowing them to detect stressed cells' such as cancer cells. Our understanding of the role of innate lymphoid cells in hepatocellular carcinoma (HCC) is growing owing to the development of mouse models, the progress in immunotherapeutic treatment and the recent use of scRNA sequencing analyses. In this review, we summarize the current understanding of NK cells and ILC1 in hepatocellular carcinoma and discuss future strategies to take advantage of these innate immune cells in anti-tumor immunity. Immunotherapies hold great promise in HCC, and a better understanding of the role and function of NK cells and ILC1 in liver cancer could pave the way for new NK cell and/or ILC1-targeted treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据